Clinic
Northwest Hospital LLC
Northwest Hospital LLC was paid $47.81M by Medicaid between Jan 2018 and Dec 2024, across 321 billing codes. Its largest line is 99284, emergency room visit (serious) — 13% of everything it billed.
33Billing provider infoNORTHWEST HOSPITAL LLC
TUCSON, AZ 85741
TUCSON, AZ 85741
33aNPI1487607784assigned 05/18/2006
33bProvider typeRadiology Clinic/Center
28Total paid$47.81M
24GClaims1,305,010
24DCodes billed321
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Radiology Clinic/Center providers in Arizona
Rank by total paid#1 of 11
Median peer was paid$55K
This provider vs. median871×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official LALOR, PAULA controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 221,842 | $7.97M | |
| 2019 | 232,942 | $8.94M | |
| 2020 | 181,919 | $6.99M | |
| 2021 | 188,612 | $6.71M | |
| 2022 | 184,560 | $6.66M | |
| 2023 | 178,271 | $6.09M | |
| 2024incomplete | 116,864 | $4.45M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 13% | 43,068 | 38,882 | $6.19M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 13% | 41,022 | 38,020 | $6.15M |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 11% | 11,104 | 10,319 | $5.46M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 9.2% | 20,816 | 18,730 | $4.39M |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 6.1% | 6,866 | 6,572 | $2.91M |
| 70450 | Computed tomography, head or brain; without contrast material | 5.6% | 10,350 | 9,530 | $2.68M |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 4.6% | 5,451 | 5,083 | $2.21M |
| 71275 | Computed tomographic angiography, chest, with contrast material | 3.2% | 3,741 | 3,535 | $1.55M |
| G0378 | Hospital observation service, per hour | 3.0% | 12,052 | 7,177 | $1.44M |
| 59025 | Fetal non-stress test | 2.5% | 8,637 | 5,422 | $1.22M |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 2.1% | 9,516 | 8,403 | $1.03M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 1.8% | 15,020 | 14,037 | $845K |
309 more codes
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 1.7% | 18,631 | $836K |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | 1.5% | 2,226 | $715K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | 1.4% | 2,045 | $687K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 1.4% | 3,357 | $669K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 1.4% | 13,080 | $658K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 1.3% | 7,624 | $632K |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | 1.1% | 1,687 | $536K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 20,734 | $433K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 12,465 | $377K |
| C1713 | Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) | <1% | 1,193 | $350K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 2,907 | $341K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 5,902 | $268K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 5,332 | $263K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 3,630 | $246K |
| 93971 | <1% | 1,915 | $222K | |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 462 | $209K |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 6,094 | $202K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 4,985 | $201K |
| 70498 | <1% | 636 | $180K | |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 173 | $149K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 2,467 | $134K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 1,429 | $123K |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 2,431 | $122K |
| 88342 | <1% | 7,946 | $117K | |
| 10060 | <1% | 635 | $115K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 1,423 | $106K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 2,312 | $102K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 5,570 | $101K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 23,230 | $95K |
| 43249 | <1% | 248 | $88K | |
| 73610 | <1% | 2,500 | $88K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 31,808 | $86K |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 158 | $86K |
| 73564 | <1% | 2,689 | $85K | |
| 73130 | <1% | 2,295 | $78K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 2,208 | $78K |
| 12001 | <1% | 783 | $71K | |
| 43235 | <1% | 233 | $68K | |
| 72100 | <1% | 2,332 | $67K | |
| 73630 | <1% | 2,997 | $65K | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 2,661 | $63K |
| 93458 | <1% | 52 | $60K | |
| 97161 | <1% | 2,154 | $60K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 326 | $59K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 814 | $54K |
| 73110 | <1% | 1,623 | $52K | |
| 47563 | <1% | 12 | $52K | |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 198 | $50K |
| 29125 | <1% | 400 | $49K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 505 | $47K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 4,143 | $43K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 2,825 | $43K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 2,954 | $41K |
| 93970 | <1% | 462 | $40K | |
| 71250 | <1% | 446 | $37K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 8,199 | $36K |
| 80053 | Comprehensive metabolic panel | <1% | 51,419 | $34K |
| 73030 | <1% | 2,484 | $34K | |
| C1776 | Joint device (implantable) | <1% | 30 | $33K |
| 58571 | <1% | 14 | $33K | |
| 86920 | <1% | 511 | $30K | |
| 36430 | <1% | 191 | $29K | |
| 71101 | <1% | 668 | $27K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 30,977 | $26K |
| 77066 | Tomosynthesis, mammo | <1% | 151 | $26K |
| 77080 | <1% | 236 | $24K | |
| 76642 | <1% | 999 | $23K | |
| 74018 | <1% | 1,809 | $22K | |
| 84484 | <1% | 22,491 | $21K | |
| 78451 | <1% | 75 | $20K | |
| 87507 | <1% | 180 | $19K | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 786 | $18K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 10,922 | $17K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 123 | $17K |
| 12011 | <1% | 289 | $17K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 5,487 | $17K |
| 70496 | <1% | 696 | $16K | |
| 73080 | <1% | 768 | $16K | |
| 72040 | <1% | 931 | $16K | |
| 70491 | <1% | 42 | $16K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 21,290 | $15K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 343 | $14K |
| 97535 | Self-care/home management training, each 15 minutes | <1% | 246 | $13K |
| 87070 | <1% | 1,087 | $13K | |
| 73502 | <1% | 1,069 | $12K | |
| 72131 | <1% | 178 | $12K | |
| 93976 | <1% | 3,481 | $12K | |
| 99205 | Prolong outpt/office vis | <1% | 146 | $12K |
| 62323 | <1% | 44 | $12K | |
| 82805 | <1% | 529 | $11K | |
| 70486 | <1% | 276 | $11K | |
| 86850 | <1% | 3,076 | $11K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 1,311 | $11K |
| 12002 | <1% | 123 | $10K | |
| 71045 | Radiologic examination, chest; single view | <1% | 19,310 | $10K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 68,158 | $9K |
| C1726 | Catheter, balloon dilatation, non-vascular | <1% | 126 | $9K |
| 97597 | <1% | 640 | $9K | |
| 77065 | Tomosynthesis, mammo | <1% | 110 | $9K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 10,957 | $9K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 19,169 | $8K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 16,288 | $7K |
| 73590 | <1% | 589 | $7K | |
| 76830 | Ultrasound, transvaginal | <1% | 1,891 | $7K |
| C1889 | Implantable/insertable device, not otherwise classified | <1% | 257 | $6K |
| 93351 | <1% | 30 | $6K | |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | <1% | 1,474 | $6K |
| 93798 | <1% | 144 | $6K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 122 | $6K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 28 | $5K |
| 97162 | <1% | 134 | $5K | |
| 93017 | <1% | 599 | $5K | |
| 93975 | <1% | 314 | $5K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 80,685 | $5K |
| 74240 | <1% | 38 | $5K | |
| 87186 | <1% | 5,224 | $3K | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 21,348 | $3K |
| 73090 | <1% | 323 | $3K | |
| 74220 | <1% | 18 | $3K | |
| 83690 | <1% | 22,813 | $2K | |
| 84703 | <1% | 17,349 | $2K | |
| 76801 | <1% | 1,533 | $2K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 11,594 | $2K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 2,788 | $2K |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 12 | $2K |
| 84702 | <1% | 3,186 | $2K | |
| 76536 | <1% | 24 | $1K | |
| 81001 | <1% | 27,444 | $1K | |
| P9016 | Red blood cells, leukocytes reduced, each unit | <1% | 160 | $1K |
| 96376 | <1% | 4,610 | $1K | |
| 72072 | <1% | 25 | $1K | |
| 73562 | <1% | 132 | $961.70 | |
| 82962 | <1% | 17,298 | $959.20 | |
| 97165 | <1% | 86 | $953.46 | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 4,324 | $929.78 |
| 80061 | Lipid panel | <1% | 1,909 | $858.55 |
| 81025 | <1% | 12,133 | $782.65 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,305 | $770.68 |
| 72128 | <1% | 12 | $770.22 | |
| 72070 | <1% | 77 | $765.90 | |
| 85379 | <1% | 4,983 | $761.30 | |
| 76775 | <1% | 70 | $743.41 | |
| C1781 | Mesh (implantable) | <1% | 46 | $735.21 |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 2,786 | $653.98 |
| 83735 | <1% | 7,503 | $641.38 | |
| 83880 | <1% | 3,423 | $567.33 | |
| 81003 | <1% | 15,865 | $559.19 | |
| 87040 | <1% | 4,541 | $554.48 | |
| 82248 | <1% | 2,824 | $545.86 | |
| 97116 | <1% | 274 | $405.44 | |
| 87081 | <1% | 2,117 | $360.61 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 12,735 | $358.01 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 2,805 | $345.75 |
| 87077 | <1% | 5,302 | $340.06 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 26,854 | $333.37 |
| 90715 | <1% | 2,437 | $321.50 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 10,713 | $300.65 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 19,523 | $258.93 |
| 85610 | <1% | 11,171 | $256.33 | |
| 73140 | <1% | 867 | $251.51 | |
| 83605 | <1% | 3,980 | $246.01 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 18,796 | $244.82 |
| 85027 | <1% | 6,034 | $243.84 | |
| 80143 | <1% | 2,641 | $208.37 | |
| 69209 | <1% | 18 | $205.52 | |
| 80179 | <1% | 2,629 | $202.96 | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 2,243 | $198.39 |
| 82077 | <1% | 3,733 | $184.85 | |
| 88307 | <1% | 440 | $166.49 | |
| 73660 | <1% | 43 | $154.62 | |
| J2060 | Injection, lorazepam, 2 mg | <1% | 4,349 | $142.91 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 6,122 | $135.91 |
| 84512 | <1% | 2,118 | $134.54 | |
| 84100 | <1% | 1,500 | $129.59 | |
| 97750 | <1% | 13 | $129.13 | |
| 86901 | <1% | 4,255 | $128.36 | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 7,195 | $127.26 |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 7,073 | $119.12 |
| 86900 | <1% | 4,257 | $114.88 | |
| 84132 | <1% | 1,243 | $112.42 | |
| 92610 | <1% | 20 | $110.57 | |
| 85730 | <1% | 3,603 | $81.45 | |
| 82150 | <1% | 2,606 | $62.53 | |
| 82550 | <1% | 1,625 | $59.12 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 4,552 | $46.75 |
| 82565 | <1% | 694 | $43.82 | |
| 87210 | <1% | 1,536 | $39.23 | |
| J0735 | Injection, clonidine hydrochloride, 1 mg | <1% | 270 | $34.33 |
| J2704 | Injection, propofol, 10 mg | <1% | 21,815 | $34.12 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 3,627 | $33.81 |
| 94760 | <1% | 5,071 | $32.00 | |
| J0780 | Injection, prochlorperazine, up to 10 mg | <1% | 1,120 | $31.76 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 13,410 | $30.94 |
| 80076 | <1% | 108 | $26.26 | |
| J2274 | Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg | <1% | 406 | $25.98 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 1,065 | $21.04 |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | <1% | 2,702 | $18.20 |
| 84439 | <1% | 139 | $16.97 | |
| J1630 | Injection, haloperidol, up to 5 mg | <1% | 926 | $14.15 |
| 86140 | <1% | 680 | $11.20 | |
| J2550 | Injection, promethazine hcl, up to 50 mg | <1% | 406 | $9.81 |
| J1956 | Injection, levofloxacin, 250 mg | <1% | 529 | $8.55 |
| 87046 | <1% | 201 | $8.22 | |
| 87205 | <1% | 1,146 | $7.56 | |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | <1% | 304 | $7.15 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 11,208 | $6.49 |
| 85651 | <1% | 390 | $5.77 | |
| J2175 | Injection, meperidine hydrochloride, per 100 mg | <1% | 1,787 | $5.34 |
| 81002 | <1% | 2,343 | $3.80 | |
| J1650 | Injection, enoxaparin sodium, 10 mg | <1% | 2,035 | $3.10 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | <1% | 1,849 | $1.38 |
| J8540 | Dexamethasone, oral, 0.25 mg | <1% | 773 | $0.04 |
| 76820 | 0% | 118 | $0.00 | |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | 0% | 1,194 | $0.00 |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | 0% | 599 | $0.00 |
| J2543 | Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) | 0% | 1,416 | $0.00 |
| C1769 | Guide wire | 0% | 2,128 | $0.00 |
| 74420 | 0% | 161 | $0.00 | |
| J0360 | Injection, hydralazine hcl, up to 20 mg | 0% | 234 | $0.00 |
| J3480 | Injection, potassium chloride, per 2 meq | 0% | 534 | $0.00 |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | 0% | 53 | $0.00 |
| 87147 | 0% | 1,278 | $0.00 | |
| J3411 | Injection, thiamine hcl, 100 mg | 0% | 287 | $0.00 |
| 87088 | 0% | 611 | $0.00 | |
| 88304 | 0% | 1,221 | $0.00 | |
| J1940 | Injection, furosemide, up to 20 mg | 0% | 308 | $0.00 |
| G8987 | Self care functional limitation, current status, at therapy episode outset and at reporting intervals | 0% | 57 | $0.00 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 0% | 697 | $0.00 |
| 99153 | Mod sedat endo service >5yrs | 0% | 375 | $0.00 |
| 82607 | 0% | 95 | $0.00 | |
| J1790 | Injection, droperidol, up to 5 mg | 0% | 643 | $0.00 |
| 77063 | Screening digital breast tomosynthesis, bilateral | 0% | 2,895 | $0.00 |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 0% | 30 | $0.00 |
| 86403 | 0% | 172 | $0.00 | |
| 88309 | 0% | 69 | $0.00 | |
| G8988 | Self care functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 0% | 60 | $0.00 |
| A9579 | Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml | 0% | 117 | $0.00 |
| J1030 | Injection, methylprednisolone acetate, 40 mg | 0% | 89 | $0.00 |
| J2370 | Injection, phenylephrine hcl, up to 1 ml | 0% | 12 | $0.00 |
| 86308 | 0% | 25 | $0.00 | |
| 82270 | 0% | 287 | $0.00 | |
| 86592 | 0% | 13 | $0.00 | |
| 82330 | 0% | 17 | $0.00 | |
| G8980 | Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting | 0% | 94 | $0.00 |
| L0625 | Lumbar orthosis, flexible, provides lumbar support, posterior extends from l-1 to below l-5 vertebra, produces intracavitary pressure to reduce load on the intervertebral discs, includes straps, closures, may include pendulous abdomen design, shoulder straps, stays, prefabricated, off-the-shelf | 0% | 41 | $0.00 |
| C1725 | Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) | 0% | 121 | $0.00 |
| J0500 | Injection, dicyclomine hcl, up to 20 mg | 0% | 147 | $0.00 |
| J0280 | Injection, aminophyllin, up to 250 mg | 0% | 58 | $0.00 |
| C2617 | Stent, non-coronary, temporary, without delivery system | 0% | 26 | $0.00 |
| 82746 | 0% | 74 | $0.00 | |
| 83550 | 0% | 13 | $0.00 | |
| 85652 | 0% | 53 | $0.00 | |
| 76870 | 0% | 45 | $0.00 | |
| J3360 | Injection, diazepam, up to 5 mg | 0% | 28 | $0.00 |
| J2470 | Injection, pantoprazole sodium, 40 mg | 0% | 40 | $0.00 |
| 82435 | 0% | 17 | $0.00 | |
| 88108 | 0% | 20 | $0.00 | |
| 85018 | 0% | 15 | $0.00 | |
| J2785 | Injection, regadenoson, 0.1 mg | 0% | 12 | $0.00 |
| S2900 | Surgical techniques requiring use of robotic surgical system (list separately in addition to code for primary procedure) | 0% | 15 | $0.00 |
| 99152 | 0% | 1,141 | $0.00 | |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | 0% | 1,465 | $0.00 |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 0% | 108 | $0.00 |
| C1758 | Catheter, ureteral | 0% | 69 | $0.00 |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | 0% | 989 | $0.00 |
| J3370 | Injection, vancomycin hcl, 500 mg | 0% | 1,728 | $0.00 |
| C9113 | Injection, pantoprazole sodium, per vial | 0% | 1,875 | $0.00 |
| 88360 | 0% | 21 | $0.00 | |
| J3475 | Injection, magnesium sulfate, per 500 mg | 0% | 581 | $0.00 |
| C1894 | Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser | 0% | 1,241 | $0.00 |
| 84550 | 0% | 138 | $0.00 | |
| J0153 | Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | 0% | 127 | $0.00 |
| J7030 | Infusion, normal saline solution , 1000 cc | 0% | 891 | $0.00 |
| 82947 | 0% | 135 | $0.00 | |
| C1887 | Catheter, guiding (may include infusion/perfusion capability) | 0% | 162 | $0.00 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 0% | 78 | $0.00 |
| 88313 | 0% | 1,757 | $0.00 | |
| 87102 | 0% | 18 | $0.00 | |
| A9576 | Injection, gadoteridol, (prohance multipack), per ml | 0% | 546 | $0.00 |
| G8979 | Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 0% | 460 | $0.00 |
| J0692 | Injection, cefepime hydrochloride, 500 mg | 0% | 59 | $0.00 |
| J1171 | Injection, hydromorphone, 0.1 mg | 0% | 98 | $0.00 |
| G8997 | Swallowing functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 0% | 14 | $0.00 |
| A9577 | Injection, gadobenate dimeglumine (multihance), per ml | 0% | 155 | $0.00 |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | 0% | 133 | $0.00 |
| 77062 | 0% | 82 | $0.00 | |
| 82140 | 0% | 50 | $0.00 | |
| G8978 | Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals | 0% | 438 | $0.00 |
| J1596 | Injection, glycopyrrolate, 0.1 mg | 0% | 232 | $0.00 |
| J1245 | Injection, dipyridamole, per 10 mg | 0% | 48 | $0.00 |
| 87075 | 0% | 14 | $0.00 | |
| 90687 | 0% | 22 | $0.00 | |
| 89051 | 0% | 33 | $0.00 | |
| 83540 | 0% | 44 | $0.00 | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 0% | 41 | $0.00 |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 0% | 27 | $0.00 |
| C1760 | Closure device, vascular (implantable/insertable) | 0% | 21 | $0.00 |
| 84295 | 0% | 18 | $0.00 | |
| 36600 | 0% | 27 | $0.00 | |
| 82570 | 0% | 43 | $0.00 | |
| 87400 | 0% | 210 | $0.00 | |
| 76125 | 0% | 24 | $0.00 | |
| 84460 | 0% | 14 | $0.00 | |
| G8996 | Swallowing functional limitation, current status at therapy episode outset and at reporting intervals | 0% | 14 | $0.00 |
| Q9957 | Injection, perflutren lipid microspheres, per ml | 0% | 12 | $0.00 |
| J1953 | Injection, levetiracetam, 10 mg | 0% | 28 | $0.00 |
| 74300 | 0% | 12 | $0.00 | |
| J0736 | Injection, clindamycin phosphate, 300 mg | 0% | 15 | $0.00 |
| 64447 | 0% | 14 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialLALOR, PAULA (DIRECTOR/DELEGATED OFFICIAL)
| Provider | Location | Paid |
|---|---|---|
| Roswell Hospital Corporation | Roswell, NM | $41.27M |
| Wesley Health System LLC | Hattiesburg, MS | $37.82M |
| Metro Knoxville Hma LLC | Powell, TN | $28.70M |
| Bullhead City Hospital Corporation | Bullhead City, AZ | $28.54M |
| Iom Health System LP | Fort Wayne, IN | $27.50M |
| ST. Joseph Health System, LLC | Fort Wayne, IN | $25.43M |
| Laredo Texas Hospital Company LP | Laredo, TX | $19.46M |
| Oak Hill Hospital Corporation | Oak Hill, WV | $18.77M |
| Cocke County Hma, LLC | Newport, TN | $18.34M |
| Cleveland Tennessee Hospital Company LLC | Cleveland, TN | $16.31M |
| Jefferson County Hma LLC | Jefferson City, TN | $14.31M |
| Northwest Arkansas Hospitals, LLC | Springdale, AR | $11.46M |
| Petersburg Hospital Company LLC | Petersburg, VA | $11.20M |
| Campbell County Hma, LLC | Lafollette, TN | $10.07M |
| Warsaw Health System LLC | Warsaw, IN | $9.95M |
| Longview Medical Center LP | Longview, TX | $9.29M |
| Moberly Hospital Company LLC | Moberly, MO | $8.61M |
| Crestview Hospital Company, LLC | Crestview, FL | $8.15M |
| Kirksville Missouri Hospital Company, LLC | Kirksville, MO | $7.98M |
| Victoria of Texas LP | Victoria, TX | $7.74M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.